We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.

Durham Research Online
You are in:

Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.

Ruigómez, A. and Hungin, A.P. and Lundborg, P. and Johansson, S. and Wallander, M.A. and Garcia Rodríguez, L.A. (2011) 'Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.', European journal of gastroenterology & hepatology., 23 (3). pp. 232-237.


Objective: Few data exist on the treatment of gastroesophageal reflux disease (GERD) in paediatrics. The objective of this study was to examine treatment patterns of GERD in paediatrics in the primary care. Methods: Incident GERD cases among paediatric patientswere identified using The Health Improvement Network UK primary care database. We assessed prescription treatments in 30 days before and any time after the date of diagnosis. Initial treatment was defined asthat received in 30 days either side of diagnosis. Odds ratios and 95% confidence intervals of receiving the treatment were calculated by multiple logistic regressions. Results: The incident GERD cohort comprised 1700 paediatric patients aged 1–17 years. Antacids were initiallyprescribed in 49.2% of patients. Similar proportions of patients (23.3 and 22.9%) received histamine-2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs); 7.5% were prescribed prokinetics and 19.3% received no prescribed treatment. Overall, 24.7% of initial H2RA users switched to PPIs, and 9.8% of those using PPIs switched toH2RAs. The likelihood of the use of PPI increased with age and was lower in girls than in boys (odds ratio: 0.7; 95% confidence interval: 0.5–0.9). Conclusions: Antacids are the drugs most frequently prescribed by primary care physicians to paediatric patients with GERD, and approximately half receive an initial course of antisecretory treatment with H2RAs or PPIs. This study suggests that treatment patterns in paediatrics differ from those in adults.

Item Type:Article
Full text:Full text not available from this repository.
Publisher Web site:
Record Created:10 Jan 2012 11:50
Last Modified:11 Feb 2015 16:40

Social bookmarking: del.icio.usConnoteaBibSonomyCiteULikeFacebookTwitterExport: EndNote, Zotero | BibTex
Look up in GoogleScholar | Find in a UK Library